364 related articles for article (PubMed ID: 25683509)
21. The protease-sensitive N-terminal polybasic region of prion protein modulates its conversion to the pathogenic prion conformer.
Zhang X; Pan YH; Chen Y; Pan C; Ma J; Yuan C; Yu G; Ma J
J Biol Chem; 2021 Nov; 297(5):101344. PubMed ID: 34710372
[TBL] [Abstract][Full Text] [Related]
22. The paraffin-embedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases.
Schulz-Schaeffer WJ; Tschöke S; Kranefuss N; Dröse W; Hause-Reitner D; Giese A; Groschup MH; Kretzschmar HA
Am J Pathol; 2000 Jan; 156(1):51-6. PubMed ID: 10623653
[TBL] [Abstract][Full Text] [Related]
23. Preventing misfolding of the prion protein by trimethylamine N-oxide.
Bennion BJ; DeMarco ML; Daggett V
Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
[TBL] [Abstract][Full Text] [Related]
24. Protein misfolding cyclic amplification of prions.
Saunders SE; Bartz JC; Shikiya RA
J Vis Exp; 2012 Nov; (69):. PubMed ID: 23168797
[TBL] [Abstract][Full Text] [Related]
25. Glypican-1 mediates both prion protein lipid raft association and disease isoform formation.
Taylor DR; Whitehouse IJ; Hooper NM
PLoS Pathog; 2009 Nov; 5(11):e1000666. PubMed ID: 19936054
[TBL] [Abstract][Full Text] [Related]
26. Prion proteins: a biological role beyond prion diseases.
Hu W; Rosenberg RN; Stüve O
Acta Neurol Scand; 2007 Aug; 116(2):75-82. PubMed ID: 17661791
[TBL] [Abstract][Full Text] [Related]
27. Anti-prion drug mPPIg5 inhibits PrP(C) conversion to PrP(Sc).
McCarthy JM; Franke M; Resenberger UK; Waldron S; Simpson JC; Tatzelt J; Appelhans D; Rogers MS
PLoS One; 2013; 8(1):e55282. PubMed ID: 23383136
[TBL] [Abstract][Full Text] [Related]
28. Towards cellular receptors for prions.
Lee KS; Linden R; Prado MA; Brentani RR; Martins VR
Rev Med Virol; 2003; 13(6):399-408. PubMed ID: 14625887
[TBL] [Abstract][Full Text] [Related]
29. Differential solubility of prions is associated in manifold phenotypes.
Kuczius T; Karch H; Groschup MH
Mol Cell Neurosci; 2009 Nov; 42(3):226-33. PubMed ID: 19607920
[TBL] [Abstract][Full Text] [Related]
30. Heterogeneity and Architecture of Pathological Prion Protein Assemblies: Time to Revisit the Molecular Basis of the Prion Replication Process?
Igel-Egalon A; Bohl J; Moudjou M; Herzog L; Reine F; Rezaei H; Béringue V
Viruses; 2019 May; 11(5):. PubMed ID: 31083283
[TBL] [Abstract][Full Text] [Related]
31. Human prion diseases: from Kuru to variant Creutzfeldt-Jakob disease.
Sikorska B; Liberski PP
Subcell Biochem; 2012; 65():457-96. PubMed ID: 23225013
[TBL] [Abstract][Full Text] [Related]
32. The retention of prion protein in the endoplasmic reticulum prevents N2A cells from proteasome inhibition-induced cytotoxicity.
Fang S; Wang R; Liu H; Zhuang W; Wang Z; Zhang J; Pei L; Liu Y; Su Y
Biochem Biophys Res Commun; 2017 Sep; 491(2):500-507. PubMed ID: 28669732
[TBL] [Abstract][Full Text] [Related]
33. Charged bipolar suramin derivatives induce aggregation of the prion protein at the cell surface and inhibit PrPSc replication.
Nunziante M; Kehler C; Maas E; Kassack MU; Groschup M; Schätzl HM
J Cell Sci; 2005 Nov; 118(Pt 21):4959-73. PubMed ID: 16219680
[TBL] [Abstract][Full Text] [Related]
34. Misfolding of the prion protein at the plasma membrane induces endocytosis, intracellular retention and degradation.
Kiachopoulos S; Heske J; Tatzelt J; Winklhofer KF
Traffic; 2004 Jun; 5(6):426-36. PubMed ID: 15117317
[TBL] [Abstract][Full Text] [Related]
35. The molecular biology of prion propagation.
Clarke AR; Jackson GS; Collinge J
Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):185-95. PubMed ID: 11260799
[TBL] [Abstract][Full Text] [Related]
36. Calpain-dependent endoproteolytic cleavage of PrPSc modulates scrapie prion propagation.
Yadavalli R; Guttmann RP; Seward T; Centers AP; Williamson RA; Telling GC
J Biol Chem; 2004 May; 279(21):21948-56. PubMed ID: 15026410
[TBL] [Abstract][Full Text] [Related]
37. PrP(Sc) of scrapie 263K propagates efficiently in spleen and muscle tissues with protein misfolding cyclic amplification.
Shi S; Dong CF; Wang GR; Wang X; An R; Chen JM; Shan B; Zhang BY; Xu K; Shi Q; Tian C; Gao C; Han J; Dong XP
Virus Res; 2009 Apr; 141(1):26-33. PubMed ID: 19162101
[TBL] [Abstract][Full Text] [Related]
38. Allelic Interference in Prion Replication Is Modulated by the Convertibility of the Interfering PrP
Espinosa JC; Andreoletti O; Marín-Moreno A; Lugan S; Aguilar-Calvo P; Cassard H; Lorenzo P; Douet JY; Villa-Díaz A; Aron N; Prieto I; Huor A; Torres JM
mBio; 2021 Mar; 12(2):. PubMed ID: 33727358
[TBL] [Abstract][Full Text] [Related]
39. Efficient in vitro amplification of a mouse-adapted scrapie prion protein.
Murayama Y; Yoshioka M; Yokoyama T; Iwamaru Y; Imamura M; Masujin K; Yoshiba S; Mohri S
Neurosci Lett; 2007 Feb; 413(3):270-3. PubMed ID: 17174030
[TBL] [Abstract][Full Text] [Related]
40. Monoacylated cellular prion protein modifies cell membranes, inhibits cell signaling, and reduces prion formation.
Bate C; Williams A
J Biol Chem; 2011 Mar; 286(11):8752-8. PubMed ID: 21212283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]